A. Presnell

High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast

Janice Patterson, M. Troxell, Neal R Olson, 2010, Modern Pathology.

The Multitargeted Receptor Tyrosine Kinase Inhibitor Linifanib (ABT-869) Induces Apoptosis through an Akt and Glycogen Synthase Kinase 3β–Dependent Pathway

K. Glaser, M. Heinrich, D. Griffith, 2011, Molecular Cancer Therapeutics.

The effect of crenolanib (CP-868596) on phosphorylation of the imatinib-resistant D842V PDGFRA activating mutation associated with advanced gastrointestinal stromal tumors.

M. Heinrich, D. Griffith, A. McKinley, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma

M. Troxell, M. Heinrich, C. Corless, 2010, Breast Cancer Research and Treatment.

Multiplex mutation screening by mass spectrometry evaluation of 820 cases from a personalized cancer medicine registry.

Laura J. Winter, B. Druker, M. Heinrich, 2011, The Journal of molecular diagnostics : JMD.

Crenolanib Inhibits the Drug-Resistant PDGFRA D842V Mutation Associated with Imatinib-Resistant Gastrointestinal Stromal Tumors

M. Heinrich, M. Debiec‐Rychter, D. Griffith, 2012, Clinical Cancer Research.

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

J. Fletcher, G. Demetri, C. Raut, 2019, British Journal of Cancer.

Sorafenib Inhibits Many Kinase Mutations Associated with Drug-Resistant Gastrointestinal Stromal Tumors

J. Fletcher, M. Heinrich, D. Griffith, 2012, Molecular Cancer Therapeutics.

Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

J. Fletcher, G. Demetri, C. Raut, 2019, British Journal of Cancer.

Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours

J. Fletcher, G. Demetri, C. Raut, 2019, British Journal of Cancer.